Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 25;6(11):ofz303.
doi: 10.1093/ofid/ofz303. eCollection 2019 Nov.

Good Fences Make Good Neighbors: Human Immunodeficiency Virus and Vascular Disease

Elizabeth S Mayne  1 , Susan Louw  2
Affiliations
Review

Good Fences Make Good Neighbors: Human Immunodeficiency Virus and Vascular Disease

Elizabeth S Mayne et al. Open Forum Infect Dis. .

Abstract

Cardiovascular disease, venous thrombosis, and microvascular disease in people with HIV (PWH) is predicted to increase in an aging HIV-infected population. Endothelial damage and dysfunction is a risk factor for cardiovascular events in PWH and is characterized by impaired vascular relaxation and decreased nitric oxide availability. Vascular disease has been attributed to direct viral effects, opportunistic infections, chronic inflammation, effects of antiretroviral therapy, and underlying comorbid conditions, like hypertension and use of tobacco. Although biomarkers have been examined to predict and prognosticate thrombotic and cardiovascular disease in this population, more comprehensive validation of risk factors is necessary to ensure patients are managed appropriately. This review examines the pathogenesis of vascular disease in PWH and summarizes the biomarkers used to predict vascular disease in this population.

Keywords: HIV; biomarkers; cardiovascular disease; endothelium; thrombosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Katz IT, Maughan-Brown B. Improved life expectancy of people living with HIV: who is left behind? Lancet HIV 2017; 4:e324–6. - PMC - PubMed
    1. Althoff KN, Smit M, Reiss P, Justice AC. HIV and ageing: improving quantity and quality of life. Curr Opin HIV AIDS 2016; 11:527–36. - PMC - PubMed
    1. Hogg RS, Eyawo O, Collins AB, et al. ; Comparative Outcomes And Service Utilization Trends (COAST) study Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study. Lancet HIV 2017; 4:e270–6. - PMC - PubMed
    1. Calmy A, Gayet-Ageron A, Montecucco F, et al. ; STACCATO Study Group HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. AIDS 2009; 23:929–39. - PubMed
    1. Auerbach E, Aboulafia DM. Venous and arterial thromboembolic complications associated with HIV infection and highly active antiretroviral therapy. Semin Thromb Hemost 2012; 38:830–8. - PubMed